Literature DB >> 19383302

Prognostic value of peripheral blood double detection of CK19 and MUC1 mRNA positive cells detected by RT-quantitative PCR in 94 breast cancer patients with a follow up of 9 years.

J-Y Pierga, F-C Bidard, M G Denis, P de Cremoux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 19383302      PMCID： PMC5543870          DOI： 10.1016/j.molonc.2007.09.005

Source DB:  PubMed          Journal:  Mol Oncol        ISSN： 1574-7891            Impact factor:   6.603


× No keyword cloud information.
  6 in total

1.  Prognostic value of peripheral blood double detection of CK19 and MUC1 mRNA positive cells detected by RT-quantitative PCR in 94 breast cancer patients with a follow up of 9 years.

Authors:  J-Y Pierga; F-C Bidard; M G Denis; P de Cremoux
Journal:  Mol Oncol       Date:  2007-09-26       Impact factor: 6.603

2.  Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.

Authors:  P de Cremoux; J M Extra; M G Denis; J Y Pierga; E Bourstyn; C Nos; K B Clough; E Boudou; E C Martin; A Müller; P Pouillart; H Magdelénat
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

3.  Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.

Authors:  Nikos Xenidis; Maria Perraki; Maria Kafousi; Stella Apostolaki; Irene Bolonaki; Aliki Stathopoulou; Kostas Kalbakis; Nikos Androulakis; Charalambos Kouroussis; Thanos Pallis; Charalambos Christophylakis; Katerina Argyraki; Evi S Lianidou; Stathis Stathopoulos; Vassilis Georgoulias; Dimitris Mavroudis
Journal:  J Clin Oncol       Date:  2006-06-12       Impact factor: 44.544

4.  Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients.

Authors:  M G Denis; C Lipart; J Leborgne; P A LeHur; J P Galmiche; M Denis; E Ruud; A Truchaud; P Lustenberger
Journal:  Int J Cancer       Date:  1997-10-21       Impact factor: 7.396

5.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

6.  Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1.

Authors:  T Felton; G C Harris; S E Pinder; D R J Snead; G I Carter; J A Bell; A Haines; J Kollias; J F R Robertson; C W Elston; I O Ellis
Journal:  Breast       Date:  2004-02       Impact factor: 4.380
  6 in total
  6 in total

1.  Prognostic value of peripheral blood double detection of CK19 and MUC1 mRNA positive cells detected by RT-quantitative PCR in 94 breast cancer patients with a follow up of 9 years.

Authors:  J-Y Pierga; F-C Bidard; M G Denis; P de Cremoux
Journal:  Mol Oncol       Date:  2007-09-26       Impact factor: 6.603

Review 2.  Circulating tumor cell isolation, culture, and downstream molecular analysis.

Authors:  Sandhya Sharma; Rachel Zhuang; Marisa Long; Mirjana Pavlovic; Yunqing Kang; Azhar Ilyas; Waseem Asghar
Journal:  Biotechnol Adv       Date:  2018-03-17       Impact factor: 14.227

3.  The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platform.

Authors:  M-h Chong; Y Zhao; J Wang; X-m Zha; X-a Liu; L-j Ling; Q Du; S Wang
Journal:  Br J Cancer       Date:  2012-04-19       Impact factor: 7.640

Review 4.  Future directions for monitoring treatment responses in breast cancer.

Authors:  Matthew P Shupe; Lindsey J Graham; Erika J Schneble; Frederick L Flynt; Michael N Clemenshaw; Aaron D Kirkpatrick; Alexander Stojadinovic; George E Peoples; Nathan M Shumway
Journal:  J Cancer       Date:  2014-01-05       Impact factor: 4.207

5.  Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer.

Authors:  Catherine Alix-Panabières; Jean-Pierre Vendrell; Monique Slijper; Olivier Pellé; Eric Barbotte; Grégoire Mercier; William Jacot; Michel Fabbro; Klaus Pantel
Journal:  Breast Cancer Res       Date:  2009-06-23       Impact factor: 6.466

Review 6.  Circulating tumor cells in breast cancer.

Authors:  Francois-Clement Bidard; Charlotte Proudhon; Jean-Yves Pierga
Journal:  Mol Oncol       Date:  2016-01-12       Impact factor: 6.603
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.